Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical
company focused on the discovery, development and commercialization of
novel protein therapeutics for cancer and rare diseases, today announced
its participation at the JMP Securities Healthcare Conference to be held
on June 24-25, 2014 at the Westin New York Grand Central Hotel in New
A live audio webcast of the presentation will be available on the
"Events and Presentations" page in the Investors & Media section on the
Company's website (http://investor.acceleronpharma.com/events.cfm).
A replay of the webcast will also be available from Acceleron's website.
Acceleron is a clinical stage biopharmaceutical company focused on the
discovery, development and commercialization of novel protein
therapeutics for cancer and rare diseases. The company is a leader in
understanding the biology of the Transforming Growth Factor-Beta (TGF-ß)
protein superfamily, a large and diverse group of molecules that are key
regulators in the growth and repair of tissues throughout the human
body, and in targeting these pathways to develop important new
medicines. Acceleron has built a highly productive R&D platform that has
generated innovative clinical and preclinical protein therapeutic
candidates with novel mechanisms of action. These protein therapeutic
candidates have the potential to significantly improve clinical outcomes
for patients with cancer and rare diseases.
For more information, please visit www.acceleronpharma.com.
[ Back To NFVZone's Homepage ]